Regulation & Compliance

With industry veteran Kevin Muskat at the helm, Leon Capital Group's new advisory practice promises M&A guidance free from audit firm conflicts.

Mount Logan Capital offers shareholders a 14% premium in a $15M tender offer, signaling confidence despite mixed financials and a complex market identity.

A new multi-million dollar partnership highlights how AI and automation are radically transforming the insurance industry's outdated payment systems.

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

Genmab discontinues its 'encouraging' lung cancer drug, acasunlimab, in a bold strategic pivot to accelerate its most promising late-stage assets.

A chiropractor with millions of followers claims he can reverse dementia. As science eyes a breakthrough, we examine the hope, the hype, and the business.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Chinese firm launches durable centrifuges for sub-zero climates and announces a major localization strategy to capture a multi-billion dollar market.

Bluejay Diagnostics can now make 9 million sepsis tests. This manufacturing win is huge, but the real race for FDA approval has only just begun.

In a strategic all-equity deal, JAPEX subsidiary Peoria Resources acquires 101,000 acres in Colorado, signaling a major pivot for the Japanese energy giant.

Fintech giant Mercury aims to become a fully regulated bank, a landmark move poised to reshape startup banking and challenge traditional finance.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

The latest VyOS release adds TLS for syslog, AWS GWLB support, and RPKI controls, boosting security and flexibility for modern network infrastructures.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

President Trump's order eases marijuana rules, but a new law threatens to dismantle the $28B hemp industry, creating unprecedented regulatory chaos.

Nuveen is combining three tax-free income funds. For investors, this means lower fees and stable payouts, but also new state tax implications.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

A Los Angeles jury found Johnson & Johnson liable for causing ovarian cancer, a landmark verdict that renews the company's legal battles over its talc products.